Key result
Among patients with cardiovascular disease, low handgrip strength was associated with a significantly higher risk of all-cause mortality (HR 3.60; 95% CI 2.21-5.86).
Why the study?
Cardiovascular disease and handgrip strength are recognized mortality risk factors, but their synergistic effect on mortality remains unclear.
Does low handgrip strength increase the risk of all-cause and CVD mortality in patients with cardiovascular disease?
Cohort (n=8,262)
Does low handgrip strength increase the risk of all-cause and CVD mortality in patients with cardiovascular disease?
Low handgrip strength is a significant predictor of increased all-cause and cardiovascular mortality in patients with cardiovascular disease.
Answers are grounded in this paper and cite their sources.
Low handgrip strength may aid mortality risk stratification in CVD; hypothesis-generating and requires prospective validation before clinical use.
BACKGROUND: Cardiovascular disease (CVD) and handgrip strength (HGS) are recognized mortality risk factors. However, the synergistic effect of CVD and HGS on mortality remains unclear. This study investigated the relationship between HGS and mortality in CVD patients. METHODS: Data from the National Health and Nutrition Examination Survey (2011-2014) were analyzed. Weighted Cox proportional hazards models and restricted cubic splines (RCS) were used to examine associations, with subgroup, sensitivity and predictive performance analyses. RESULTS: Among 8,262 adults (50.56% female; 851 with CVD), 695 deaths (6.74%) occurred over a median follow-up of 80 months. Compared to non‒CVD individuals with high-HGS, CVD patients with low-HGS had the highest risk of all-cause mortality [hazard ratio (HR) = 8.76; 95% CI: 4.20-18.30] and CVD mortality (HR = 4.83; 95% CI: 3.48-6.70), while CVD patients with high-HGS showed no significant mortality risk increase. Among CVD patients, the HRs for all-cause and CVD mortality in the low-HGS group were 3.60 (95% CI, 2.21-5.86) and 4.01 (95% CI, 1.68-9.59). RCS analyses revealed that the relationships were linear (P‒nonlinear >0.05), and subgroup analyses revealed stroke status potentially modified the association for CVD mortality (P‒interaction = 0.002). The addition of HGS significantly improved the predictive performance of current models for mortality (P < 0.001). CONCLUSION: Low HGS may be associated with a higher risk of all-cause and CVD mortality among CVD patients. High HGS appears to reduce mortality risk among CVD patients. These findings suggest that HGS may serve as a valuable predictor of mortality risk in CVD patients.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2024) conducted a cohort in Cardiovascular disease (n=8,262). Low handgrip strength vs. High handgrip strength was evaluated on All-cause mortality (HR 3.60, 95% CI 2.21-5.86). Among patients with cardiovascular disease, low handgrip strength was associated with a significantly higher risk of all-cause mortality (HR 3.60; 95% CI 2.21-5.86).
Synapse has enriched 10 related papers. Consider them for comparative context: